Angion Biomedica
Clinical stage organ restoration biopharmaceutical company focused on renal disease. Learn more
Launch date
Employees
Market cap
€274m
Enterprise valuation
€247m (Public information from Jun 2023)
Share price
$1 ANGN
Hempstead New York (HQ)
Authorizing premium user...